Jeanette E Boudreau (Jeanette Boudreau)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Highly Efficient

Top Venues

Journal of clinical medicine

Biochemistry and cell biology = Biochimie et biologie cellulaire

Current treatment options in oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Stacey N Lee, Victoria Hoskin, Céline M Laumont, Shannon Snelling, Lorenzo Lindo, Lou Bird, Vera Samarkina, Chantale Thurston, Grace Fox, Sarah Ivanco, Megan Mahoney, Jeanette E Boudreau, Sarah Nersesian
BioCanRx Summit for Cancer Immunotherapy 2022 Proceedings. Biochemistry and cell biology = Biochimie et biologie cellulaire (2023)
Emily B Carter, Morgan Pugh-Toole, Ahmed Kabil, Jeanette E Boudreau, Sarah Nersesian
The Canadian Society for Immunology's 34th annual meeting 2022: symposia minireview. Journal of leukocyte biology (2023)
Morgan Pugh-Toole, Anna P Nicolela, Sarah Nersesian, Brendan M Leung, Jeanette E Boudreau
Natural Killer Cells: the Missing Link in Effective Treatment for High-Grade Serous Ovarian Carcinoma. Current treatment options in oncology 23 (2) (2022)
Ryan C DeCoste, Yutaka Amemiya, Sarah Nersesian, Lauren Westhaver, Stacey N Lee, Michael D Carter, Heidi L Sapp, Ashley E Stueck, Thomas Arnason, Jeanette E Boudreau, Arun Seth, Weei-Yuarn Huang
PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology. Journal of clinical medicine 11 (14) (2022)
Breanna K V Hargreaves, Sarah E Roberts, Beata Derfalvi, Jeanette E Boudreau
Highly efficient serum-free manipulation of miRNA in human NK cells without loss of viability or phenotypic alterations is accomplished with TransIT-TKO. PloS one 15 (4) (2020)
Sarah K A Savoy, Jeanette E Boudreau
The Evolutionary Arms Race between Virus and NK Cells: Diversity Enables Population-Level Virus Control. Viruses 11 (10) (2019)